The publisher is not a healthcare provider and does not provide medical advice
Novel, in-vivo and in vitro data suggest that exenatide, a GLP-1 receptor agonist, may represent an ideal therapy for IIH through rapid reduction of CSF secretion at the choroid plexus, lowering ICP in addition to its weight loss properties
Hormones, particularly estrogen, also play a significant role by influencing fat storage and the elasticity of connective tissues
Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease
Managing diabetes medications safely Whether you take Tresiba, a GLP-1 medication, or both, safe management requires understanding what each medication does and how to use it properly
Accordingly, the diabetes drug market is expected to balloon from $29.81 billion in 2021 to $61.6 billion by 2030